HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Improved trial design, education needed to optimize geriatric oncology care
-
- Study offers ‘intriguing’ insights into post-cardiac surgery thrombocytopenia Harry S. Jacob, MD, DHC
- Cancer awareness months: Are we missing an opportunity or missing the point? John Sweetenham, MD, FRCP, FACP
- FDA approves OxyContin for use in adolescents
- FDA expands approval of Promacta for pediatric patients with ITP
- FDA approves Varubi for chemotherapy-induced nausea, vomiting
- FDA grants breakthrough drug designation to cabozantinib for advanced renal cell carcinoma
- FDA grants orphan drug designation to Gilotrif for advanced squamous cell lung carcinoma
- FDA grants orphan drug designation to MTG-201 for malignant mesothelioma
-
- FDA grants orphan drug designation to Toca 511 & Toca FC for glioblastoma
- FDA grants priority review to MCNA for nonmuscle-invasive bladder cancer
- Anticoagulants safe for patients with brain metastases
- Axillary node evaluation common in DCIS, despite uncertain benefits
- Baseline caspase levels may serve as biomarker in advanced SCCHN
- Bone marrow toxicity limited in most patients after radioiodine therapy for DTC
- ACS: Cancer risk behaviors remain high
- CDC: Melanoma rates doubled in 30 years
-
- Combination therapy confers positive outcomes for peripheral T-cell lymphoma
- Common antibiotic may decrease anticoagulant effect of warfarin
- Compliance with posttreatment surveillance improves survival for head, neck cancers
- Copy number alterations predict poor prognosis in adult ALL
- Cyramza does not significantly improve OS in patients with advanced HCC
- Doublet therapy safe, effective in heavily pretreated non-Hodgkin's lymphoma
- Early docetaxel-based chemotherapy may improve survival for high-risk localized prostate cancer
- Eltrombopag safe, effective for children with chronic immune thrombocytopenia
-
- Engineered protein safely, effectively controls bleeding in severe von Willebrand's disease
- Failure-to-rescue rates following lung resection greater at high-mortality hospitals
- Genetic testing may improve myeloma risk stratification, treatment
- GI bleeding risk higher with novel anticoagulants than warfarin in older patients
- H. pylori eradication may reduce gastric cancer incidence
- Haploidentical, unrelated donor transplantation yield similar OS outcomes for AML
- Higher CD8 T-cell dose from younger donors improves allogeneic HSCT outcomes
- Higher response rate seen with T-VEC in advanced melanoma
-
- Immune perturbations may increase melanoma risk among certain non-Hodgkin's lymphoma survivors
- Improved surveillance, prophylaxis suggested for CMV in pediatric bone marrow transplantation
- Low-risk tumor imaging leads to increased thyroid cancer rates
- Lymphoma survivors face increased risk for cardiac problems after HSCT
- Melanoma may metastasize in less radioactive sentinel lymph nodes
- Next-generation sequencing cost-effective for evaluation of inherited colorectal cancer, polyposis syndromes
- Panel: Public health will benefit by raising legal age to purchase tobacco
- Paternal age at birth, sibling status linked to blood cancer risk
-
- Patients prefer expediency of telephone communication to receive skin biopsy results
- Patients with in situ melanoma at higher risk for subsequent melanoma after 2 years
- Patients with luminal A breast cancer may not benefit from radiation therapy
- Primary chemotherapy noninferior to surgery in advanced ovarian cancer
- Radiofrequency ablation safe, effective for medically inoperable NSCLC
- Reporting of serious AEs to FDA often delayed by drug companies
- Responsible data-sharing calls for guiding principles to maximize benefits, lower risks
- Review examines clinical, practice implications of direct-acting oral anticoagulants
-
- Rise in health data breaches driven by criminal activity
- Risk of MGUS, multiple myeloma greater in Vietnam veterans exposed to Agent Orange
- Survivors of young adult cancers face increased hospitalization risk into adulthood
- Thyroid radiation dose, other factors may predict carcinoma risk after childhood cancer
- Tinzaparin fails to significantly reduce recurrent VTE compared with warfarin
- Tivantinib, erlotinib improve PFS, not OS in advanced NSCLC
- Vegetarian diet associated with lower risk for colorectal cancer
- VTE rates following colorectal surgery remain stable despite increased prophylaxis
-
- Waldenström's macroglobulinemia outcomes improve in past decade
- Most young patients with lung cancer harbor targetable mutations
- Smoking cessation reduces mortality among patients receiving active screening for lung cancer